Cargando…

Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis

BACKGROUND: Individuals with cardiac sarcoidosis have an increased risk of ventricular arrhythmia and death. Several small cohort studies have evaluated the ability of late gadolinium enhancement (LGE) by cardiac magnetic resonance imaging (MRI) to predict adverse cardiovascular events. However, stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hulten, Edward, Agarwal, Vikram, Cahill, Michael, Cole, Geoff, Vita, Tomas, Parrish, Scott, Bittencourt, Marcio Sommer, Murthy, Venkatesh L., Kwong, Raymond, Di Carli, Marcelo F., Blankstein, Ron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449111/ https://www.ncbi.nlm.nih.gov/pubmed/27621357 http://dx.doi.org/10.1161/CIRCIMAGING.116.005001

Ejemplares similares

Assessment of Cardiac Masses by Cardiac Magnetic Resonance Imaging: Histological Correlation and Clinical Outcomes
por: Mousavi, Negareh, et al.
Publicado: (2019)

Can late gadolinium enhancement on cardiovascular magnetic resonance describe cardiac involvement in patients with systemic sarcoidosis and/or suspect of cardiac involvement of sarcoidosis with cardiac symptoms?
por: Kasai, Yufuko, et al.
Publicado: (2011)

Intra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathy
por: Sano, Makoto, et al.
Publicado: (2016)

Imaging in Suspected Cardiac Sarcoidosis: A Diagnostic Challenge
por: Ha, Francis J., et al.
Publicado: (2020)

Combined stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance provides robust prognostic information to cardiac events
por: Coelho-Filho, Otavio, et al.
Publicado: (2011)

Cardiac Sarcoidosis: When and How to Treat Inflammation
por: Giblin, Gerard T, et al.
Publicado: (2021)

Accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis
por: Tzogias, Leonidas, et al.
Publicado: (2009)

Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis
por: Gräni, Christoph, et al.
Publicado: (2019)

Right ventricle late gadolinium enhancement in cardiac sarcoidosis: a case series
por: Lydell, Carmen P, et al.
Publicado: (2011)

Magnetic resonance imaging of cardiac sarcoidosis: an evaluation of the cardiac segments and layers that exhibit late gadolinium enhancement
por: Komada, Tomohiro, et al.
Publicado: (2016)

Stress cardiac magnetic resonance imaging effectively reclassifies risk in patients with known or suspected stable coronary artery disease
por: Feng, Jiazuo H, et al.
Publicado: (2013)

Feasibility study of electrocardiographic and respiratory gated, gadolinium enhanced magnetic resonance angiography of pulmonary veins and the impact of heart rate and rhythm on study quality
por: Groarke, John D, et al.
Publicado: (2014)

Suspected Isolated Cardiac Sarcoidosis Initially Presenting as Sustained Ventricular Tachycardia
por: Sufian, Abu
Publicado: (2023)

Value of late gadolinium enhancement by magnetic resonance in patients with cardiac sarcoidosis: characteristic findings and clinical utility
por: Watanabe, Eri, et al.
Publicado: (2009)

Late gadolinium enhancement and T2 MR imaging features of cardiac sarcoidosis involving the left and right ventricle
por: Cherian, Varghese, et al.
Publicado: (2009)

The impact of the COVID-19 pandemic on cardiac CT
por: Blankstein, Ron
Publicado: (2020)

Refining risk assessment in cardiac sarcoidosis: a role for burden of late gadolinium enhancement and right ventricular function
por: Murtagh, Gillian, et al.
Publicado: (2014)

Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with suspected myocardial ischemia
por: Steel, Kevin, et al.
Publicado: (2009)

Myocardial tissue changes detected by cardiac MRI in a patient with suspected systemic sarcoidosis
por: Vanchin, Byambasuren, et al.
Publicado: (2023)

Challenges of cardiac sarcoidosis
por: Strambu, Irina R.
Publicado: (2023)

Role of cardiovascular magnetic resonance in suspected cardiac amyloidosis: late gadolinium enhancement pattern as mortality predictor
por: Baroni, M., et al.
Publicado: (2017)

Association of Arrhythmias in Cardiac Amyloidosis and Cardiac Sarcoidosis
por: Ashraf, Ibtisam, et al.
Publicado: (2020)

Obesity, metabolic syndrome and cardiovascular prognosis: from the Partners coronary computed tomography angiography registry
por: Hulten, Edward A., et al.
Publicado: (2017)

Features and clinical impact of extra-cardiac lesions with (18)F-fluorodeoxyglucose positron emission tomography in patients with suspected cardiac sarcoidosis
por: Higashi, Haruhiko, et al.
Publicado: (2020)

Reconciling Q waves and late gadolinium enhancement with no angiographic evidence of coronary disease: cardiac sarcoidosis presenting as decompensated heart failure
por: MORRISSEY,, RYAN P, et al.
Publicado: (2010)

Arrhythmia Monitoring and Outcomes in Patients With Cardiac Sarcoidosis: Insights From the Cardiac Sarcoidosis Consortium
por: Bressi, Edoardo, et al.
Publicado: (2022)

Clinical Diagnosis of Cardiac Sarcoidosis Improves Treatment Effectiveness and Unmasks Isolated Cardiac Sarcoidosis
por: Yamamoto, Kazuhiro
Publicado: (2021)

Fulminant cardiogenic shock due to cardiac sarcoidosis
por: Genovese, Leonard, et al.
Publicado: (2021)

Prognostic Value of T1 Mapping and Feature Tracking by Cardiac Magnetic Resonance in Patients With Signs and Symptoms Suspecting Heart Failure and No Clinical Evidence of Coronary Artery Disease
por: Seno, Ayako, et al.
Publicado: (2022)

Novel quantification of extracellular expansion by cardiac magnetic resonance is a robust marker in diagnosis of cardiac amyloidosis
por: Mongeon, Francois-Pierre, et al.
Publicado: (2011)

Cardiac Sarcoidosis: Oldies but Not Goodies
por: Sohn, Il-Suk
Publicado: (2011)

CMR Features in Cardiac Sarcoidosis
por: Prasher, Sparsh, et al.
Publicado: (2011)

Management of Cardiac Sarcoidosis in 2020
por: Gilotra, Nisha, et al.
Publicado: (2020)

Cardiac MRI and FDG-PET in the diagnosis of cardiac sarcoidosis
por: Coulden, Richard, et al.
Publicado: (2014)

Cardiac magnetic resonance imaging–negative cardiac sarcoidosis
por: Yung, See-Yue Arthur, et al.
Publicado: (2021)

Cardiac sarcoidosis mimics cardiac amyloidosis in an elderly patient
por: Kafil, Tahir S, et al.
Publicado: (2022)

Bi-atrial fibrosis detected using three-dimensional late gadolinium enhancement magnetic resonance imaging in a patient with cardiac sarcoidosis(⋆)
por: Spence, Stewart, et al.
Publicado: (2018)

CASPA (CArdiac Sarcoidosis in PApworth) improving the diagnosis of cardiac involvement in patients with pulmonary sarcoidosis: protocol for a prospective observational cohort study
por: Quijano-Campos, Juan Carlos, et al.
Publicado: (2020)

Cardiac Magnetic Resonance in Patients with Suspected Tachycardia-Induced Cardiomyopathy: The Impact of Late Gadolinium Enhancement and Epicardial Fat Tissue
por: Orlov, Oleg, et al.
Publicado: (2023)

Underdiagnosis of cardiac sarcoidosis by ECG and echocardiography in cases of extracardiac sarcoidosis
por: Ohira, Hiroshi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v0uutnsqb5s50rb706lo250rsm